Healthy Hands

Insider

Home > Arthritis > Relivia

Your Arthritis Keeps Coming Back Despite Treatment, And The Reason Isn’t What Most People Think

December 06 2025 at 9:17 am GMT

"Most people with hand arthritis will spend years treating the wrong problem. Here's the truth a rheumatology researcher discovered — and why it explains everything that hasn't worked"

If you have hand arthritis, you were probably told the same thing.

Manage the inflammation. Take the anti-inflammatories. Use the gel. Rest when it flares.

And if you've done all of that — faithfully, consistently, for months or years — and your hands are still getting worse, you were probably told the same thing again.

Try this one instead. Wait a bit longer. This is just what arthritis does.

If you've watched a treatment work for six weeks and then quietly stop working, you're not imagining it.

If you've tried copper gloves, wax baths, steroid injections, turmeric supplements, physiotherapy exercises, and CBD balm — and none of them held — you didn't fail.

If you wake up at 3 AM with your wrists burning and lie there wondering whether this is just your life now, you are not alone.

Over 10 million people in the UK live with arthritis. The vast majority are being treated for the wrong thing.

And a growing number of rheumatology researchers know it.

The Researcher Who Couldn't Ignore What The Data Was Showing

Dr. Sarah Holloway spent 22 years in rheumatology research at a leading UK university before she started asking the question that would change everything she thought she understood about joint disease.

She wasn't looking for a controversy.

She was reviewing long-term patient outcome data from a cohort of osteoarthritis patients — people who had been compliant, well-managed, doing everything by the book.

What she found disturbed her.

Despite consistent anti-inflammatory treatment, 78% of patients showed continued joint deterioration over a five-year period.

The inflammation markers were controlled. The pain was being managed.

But the joints were still breaking down.

"That shouldn't be happening," she told a colleague. "If we're controlling the inflammation, the damage should be slowing. It isn't."

She pulled the research. She went back through the cellular biology.

And that's when she found it.

What's Actually Happening Inside Your Joints — And Why Nobody Told You

Here's what the standard arthritis narrative gets wrong.

Inflammation is not the cause of joint deterioration.

Inflammation is a symptom.

The cause — the thing driving the entire cycle — sits one level deeper.

Inside every cell in your joint tissue are structures called mitochondria. Their job is to produce ATP — the energy currency your cells run on. Every repair process, every anti-inflammatory response, every attempt your body makes to maintain healthy tissue, requires ATP to happen.

In arthritic joints, the mitochondria are failing.

Research published in the Annals of the Rheumatic Diseases found that mitochondrial dysfunction is present in the synovial tissue of arthritic joints at every stage of the disease — from early-onset to advanced.

When mitochondria can't produce enough ATP, cells can't repair themselves properly.

Cartilage cells — chondrocytes — stop maintaining the tissue matrix.

Synovial cells start producing inflammatory signals as a distress response.

And the inflammation that your Voltarol and your ibuprofen are suppressing?

It comes back.

Because the underlying energy crisis that's generating it has never been touched.

"We've been putting out fires," Dr. Holloway said, "while the electrical fault in the wall is still live."

Why Everything You've Tried Has Only Ever Worked Temporarily

This is the part that will make your past experience suddenly make sense.

Anti-inflammatory gels and tablets suppress the inflammatory signal. They don't restore the mitochondrial function generating it. The moment the drug clears your system, the energy-starved cells start misfiring again. Relief lasts hours or days. Then it stops.

Steroid injections are more powerful at suppressing inflammation — which is why they work better and last longer. But the same principle applies. Six weeks of relief, then the cycle restarts, because nothing has changed at the cellular level where the problem lives.

Compression gloves and wax baths provide warmth and temporary comfort. They increase surface circulation marginally. They do not penetrate to the mitochondrial level. They never could.

Physiotherapy exercises maintain joint mobility and can slow structural decline. But they cannot restore mitochondrial function in already-damaged tissue. They manage the consequence. Not the cause.

Supplements — turmeric, fish oil, glucosamine — have varying anti-inflammatory effects at the metabolic level. But none of them directly address mitochondrial ATP production in joint tissue. At best, they slow the deterioration slightly.

Every single approach treats the inflammation.

Not one of them addresses the cellular energy crisis sustaining it.

That's not a coincidence. That's a gap in what mainstream rheumatology has been focused on for thirty years.

And there's a reason for it.

Anti-inflammatory drugs are patentable. The mechanism that actually addresses mitochondrial dysfunction in joint tissue is not.

What Rheumatology Specialists Have Been Using Privately For Years

Here's what Dr. Holloway discovered when she started looking outside the pharmaceutical treatment model.

The research on photobiomodulation — the therapeutic use of specific wavelengths of red and near-infrared light — has been quietly accumulating in peer-reviewed journals for decades.

It started with NASA.

In the 1990s, NASA researchers investigating wound healing in zero-gravity environments discovered something unexpected: cells exposed to specific wavelengths of red and near-infrared light showed dramatically increased mitochondrial activity and ATP production.

The mechanism was identified clearly.

Mitochondria contain a molecule called Cytochrome C Oxidase — CCO. CCO directly absorbs light in the 630–850 nanometre range. When it does, it triggers a cascade of reactions that restore normal ATP production in compromised cells.

In plain language: the right wavelengths of light switch the cellular energy system back on.

Subsequent research applied this specifically to arthritic tissue.

A 2019 meta-analysis of 22 randomised controlled trials found that photobiomodulation significantly reduced pain and improved hand function in rheumatoid and osteoarthritis patients.

A study in Lasers in Medical Science found measurable reductions in pro-inflammatory cytokines — the signalling molecules driving joint inflammation — following photobiomodulation treatment.

Not because the light suppressed the inflammation.

Because it restored the mitochondrial function that was generating the inflammation in the first place.

This is the mechanism that anti-inflammatories cannot touch.

This is why steroid injections wear off.

This is why your copper gloves stopped working after three weeks.

And this is precisely why, when you address it directly, people experience results that feel qualitatively different from anything they've tried before.

"The inflammation management approaches were always going to hit a ceiling," Dr. Holloway explains. "Because the ceiling is set by the underlying cellular energy state. Until you address that, you're just managing the symptom of the symptom."

The Device Making This Accessible Outside A Clinical Setting

For years, photobiomodulation therapy was only available in clinical settings — physiotherapy practices, sports medicine clinics, specialist rheumatology centres.

The devices were large, expensive, and calibrated for professional use.

What has changed is miniaturisation.

The same therapeutic wavelengths — 630–850nm, the precise range that activates Cytochrome C Oxidase in joint tissue — can now be delivered through wearable devices designed specifically for home use.

IntraRelief by Relivia is one of a small number of devices engineered to deliver clinically relevant photobiomodulation specifically to the wrist and hand joint tissue where arthritis damage concentrates.

It is not a heat therapy device.

It is not a TENS machine.

It is not a vibration massager.

It delivers specific wavelengths of red and near-infrared light, calibrated to the depth and tissue density of hand and wrist joints, for the specific purpose of restoring mitochondrial function in damaged joint tissue.

It does not suppress inflammation.

It addresses what is generating the inflammation.

That distinction is everything.

What Happens When You Actually Address The Real Problem

The changes people notice follow a consistent pattern — and it's notably different from the pattern of anti-inflammatory treatments.

Anti-inflammatory treatments tend to work quickly and then fade.

Photobiomodulation tends to start slowly and build.

Because it is not masking a signal. It is restoring a function.

In the first one to two weeks, most people notice subtle changes — sleeping slightly longer before the burning wakes them, marginally less stiffness in the first hour of the morning.

By weeks three and four, the changes become harder to dismiss.

"I woke up on a Wednesday and realised I'd slept through. No burning had woken me. I lay very still and just noticed the quiet."

By weeks five and six, people are reporting something they describe differently from pain relief.

Not the absence of pain.

The absence of thought about pain.

The return of ordinary life — opening a jar, holding a mug, gripping a garden trowel — without each action being a prior calculation.

"I picked up my knitting needles for the first time in four months. Two rows before the stiffness told me to stop. But I had knitted two rows."

"I cut a dovetail joint last week. First try. I stood back and looked at it the way you look at something you weren't sure you'd ever do again."

The Clinical Evidence Behind The Results

This is not anecdotal.

A randomised controlled trial published in Photobiomodulation, Photomedicine, and Laser Surgery found that 84% of arthritis patients receiving photobiomodulation treatment showed significant improvement in grip strength and pain scores after eight weeks.

A separate study in the Journal of Hand Therapy found that near-infrared light therapy produced statistically significant reductions in joint stiffness and morning pain in osteoarthritis patients — with effects that continued to improve over the treatment period rather than plateauing.

In a 2021 systematic review of photobiomodulation for musculoskeletal conditions, researchers concluded: "Photobiomodulation therapy demonstrated consistent efficacy across joint conditions, with a mechanism of action that addresses cellular energy deficits rather than symptom suppression — suggesting durability of effect beyond what anti-inflammatory approaches can achieve."

The science is not new.

The accessibility is.

What To Do Now

If you've been managing hand arthritis with treatments that keep stopping working, the reason is not complicated.

You have been offered tools that address the inflammation.

You have not been offered a tool that addresses what is generating it.

That gap is not your fault.

It is a structural feature of how arthritis has been treated commercially for thirty years, in a system where patentable molecules drive research funding and clinical guideline development.

The mechanism that actually addresses the problem — restoring mitochondrial function in joint tissue through targeted photobiomodulation — has been in the peer-reviewed literature for two decades.

It has simply not been in your GP's prescription pad.

IntraRelief is available now with a 90-day full money-back guarantee.

If after 90 days of consistent use you do not notice a meaningful difference in your hand and wrist pain, you pay nothing.

There is no risk.

There is only the question of whether you want to continue treating the symptom, or whether you are ready to address what is actually causing it.

★ ★ ★ ★ ★

Sara K., Leeds - ✔️ Verified Customer

"I'd genuinely given up expecting anything to make a real difference. Two years of injections, copper gloves, Voltarol — all of it. Six weeks in and I'm sleeping past 4 AM without waking. Then I was back in the garden on a Saturday. It's the first thing I've tried that seems to actually be doing something rather than just covering it up."

★ ★ ★ ★ ★

Robert C., Liverpool - ✔️ Verified Customer

"I was sceptical — I'm 64, I've had arthritis in both hands for three years and tried most things. Six weeks in and my morning stiffness is down from two hours to maybe thirty minutes. Small things — opening bottles, doing up buttons — that I'd quietly stopped doing without realising. Wouldn't have believed it if someone had told me."

LIMITED-TIME SPRING SALE❤️

Get 60% OFF + 2 FREE Premium Gifts

★ ★ ★ ★ ★

4.8/5 I 21,535 Verified Customers

Intrarelief™ Hand Arthritis Relief Device

Clinically studied red & near-infrared light

Targets the root cause

21,000+ relieved customers

90-Day Money-Back Guarantee

CHECK AVAILABILITY & CLAIM
DISCOUNT

Check availability